Track Order   | Customer Support   | Request Book   |
International Order
Adoptive Immunotherapy: Methods And Protocols at Meripustak

Adoptive Immunotherapy: Methods And Protocols

Books from same Author: Burkhard Ludewig   Matthias W. Hoffmann

Books from same Publisher: Humana Press Inc.

Related Category: Author List / Publisher List

  • Retail Price: ₹ 17552/- [ 20.00% off ]

    Seller Price: ₹ 14041

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 20.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 20.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available


Click for International Orders
  • Provide Fastest Delivery
  • 100% Original Guaranteed
    • General Information  
    Author(s)Burkhard Ludewig   Matthias W. Hoffmann
    PublisherHumana Press Inc.
    Edition2005 ed.
    ISBN9781588294067
    Pages500
    BindingHardback
    LanguageEnglish
    Publish YearDecember 2004

    Description

    Humana Press Inc. Adoptive Immunotherapy: Methods And Protocols by Burkhard Ludewig   Matthias W. Hoffmann

    An authoritative collection of optimal techniques for producing and characterizing the immunologically active cells and effector molecules now gaining wide use in the clinical treatment of patients. Taking advantage of the latest technologies the authors present readily reproducible experimental protocols for the study of dendritic cells T cells monoclonal antibodies and bone marrow transplantation. The emphasis is on preclinicical and clinical applications and on the progress of selected approaches in clinical trials. Additional chapters cover the molecular definition of target antigens mathematical modeling approaches to immunotherapy and the utilization of regulatory T cells. The protocols make it possible to study the adoptive transfer of tailored antigen-specific immune cells and to improve the clinical application of adoptive immunotherapy.